Speakers Bureau View
241 Profile Views
-
144 Presentation Views
Lexie Shannon Holliday
ASSOCIATE PROFESSOR
| Bis-enoxacin: Development of a new drug for osteoporosis and bone cancer | |
| Audience: | Adults |
| Description: | Development of new therapeutic agents has until recently relied on luck, or brute force (testing hundreds of thousands of molecules to find one that works). Now supercomputer-based computational chemistry has reached sufficent levels of sophistication to allow rational drug design and development. In this presentation, I will decribe studies in my laboratory, which led to the identification of a new and better anti-resorptive for the treatment of osteoporosis and bone cancer. This is an example of what can be done in the area of rational drug design. |
| Subject Areas: |
Biotechnology Medical Sciences Science |
| Keywords: |
Bone Disease Cancer Cell Biology Computers Molecular biology |
| Duration: | 1 hour or less |
| Fee: | Expenses Only |
| Comments: | I would be happy to accept an honorarium if one is provided. |
Share